Vicente Boix to Treatment Outcome
This is a "connection" page, showing publications Vicente Boix has written about Treatment Outcome.
Connection Strength
0.015
-
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study. J Autoimmun. 2020 11; 114:102523.
Score: 0.008
-
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study. PLoS One. 2018; 13(6):e0198768.
Score: 0.007